Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
NephrosNEPH | Open-market buy | 24/05/28–24/05/30 | 24/05/30 | 5,000 sh2 trades | $2.23avg. | $11,160 | +5.1% | |
Robert R. Banks Jr.President and CEO | NephrosNEPH | Open-market buy | 24/05/16 | 24/05/16 | 50,000 sh | $2.24 | $112,000 | +250.0% |
Arthur H. AmronDirector | NephrosNEPH | Open-market buy | 24/03/12 | 24/03/14 | 7,000 sh | $2.45 | $17,150 | No record |
Robert R. Banks Jr.President and CEO | NephrosNEPH | Open-market buy | 23/12/07 | 23/12/11 | 18,000 sh | $2.20 | $39,600 | +900.0% |
NephrosNEPH | Open-market buy | 23/08/14–23/08/15 | 23/08/15 | 2,000 sh2 trades | $1.68avg. | $3,361.19 | No record |